• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
The Reserve Bank of Australia will release the minutes of its December monetary policy meeting in ten minutes.The yield on 40-year Japanese government bonds fell 1.0 basis point to 3.705%.December 23 - According to the Sing Tao Daily, Biren Technology began accepting subscriptions for its Hong Kong initial public offering (IPO) on Monday, with margin financing oversubscribed by nearly 47 times on the first day. The company plans to issue 247.7 million shares, aiming to raise up to HK$4.85 billion.On December 23, the U.S. Food and Drug Administration (FDA) approved the oral tablet version of Novo Nordisks weight-loss drug Wegovy. Novo Nordisk refers to the drug as Wegovy oral tablets. Its active ingredient is the same as the original Wegovy and its diabetes sister drug Ozempic, both being semaglutide. Wegovy and Ozempic are both weekly injectable GLP-1 hormone mimics, as are their competitors Eli Lillys Zepbound and Mounjaro. According to the Kaiser Family Foundation, a health policy research organization, approximately one in eight adults in the U.S. are currently taking one of these medications. Novo Nordisk stated that clinical trials showed that the weight-loss effects and side effects of Wegovy oral tablets are broadly similar to those of the Wegovy injection, and it will be available in the U.S. with a prescription starting in January. Novo Nordisks Chief Medical Officer for the U.S., Brett, stated, "We believe this will expand patient choice and accessibility; we know some patients simply do not want to use injectable medications."December 23 – Since the Trump administration tightened restrictions on Venezuelan oil revenues by locking down tankers, more than a dozen oil tankers have been loading oil off the Venezuelan coast. According to shipping intelligence firm Kepler, approximately 14 vessels have completed loading since December 11, at least six of which are sanctioned. Most loading operations have taken place in the ports of Bajo Grande and Jose. Data shows that despite escalating tensions, oil loading activity is proceeding at a near-normal pace.

The USD/JPY exchange rate is anticipated to resume its ascent from 132.00 as the BOJ favors greater policy easing

Alina Haynes

Jan 05, 2023 15:05

 USD:JPY.png

 

The USD/JPY pair has gradually retraced approaching the crucial support level of 132.00 in the early Asian session. Following a big increase to approximately 132.70, the asset is seeing weak selling pressure. The major may resume its ascent despite the risk-on market mentality, as the Bank of Japan (BOJ) has supported greater policy easing to bolster wages.

 

As the Federal Reserve (Fed) is projected to lower the rate of interest rate hikes, the S&P500 exhibited a stronger recovery on Wednesday following a two-day fall.

 

The US Dollar Index (DXY) dropped sharply below 104.00 as an adjustment to the Fed's sluggish pace of policy tightening anticipated a reduction in the US price index for goods and services. In addition, the yield on US Treasury bonds has increased due to the majority of Fed policymakers' support for a slower rate of interest rate increases. The yield on 10-year US Treasuries has declined to approximately 3.69 percent.

 

Investors will await the release of the United States Automatic Data Processing (ADP) Employment Change (Dec), which is projected to be 150K, up from the previous release of 127K. In contrast, the US Nonfarm Payrolls (NFP) report reveals a rise of 200K jobs compared to the previous estimate of 263K. The US Institute of Supply Management's (ISM) report of a decline in manufacturing activity and the Federal Reserve's decision to increase interest rates increase predictions of a slowed employment creation process.

 

After BOJ Governor Haruhiko Kuroda pushed for greater policy easing to drive the wage price index in order to meet higher inflation projections for CY2023 and CY2024, the Japanese yen experienced a strong fall in Tokyo.